Dimt1-KO Mouse
一般名
Dimt1-KO
製品ID
S-KO-18494
背景情報
C57BL/6JCya
系統ID
KOCMP-66254-Dimt1-B6J-VB
状況
このマウス系統を論文で使用する場合は、「Dimt1-KO Mouse(カタログ番号S-KO-18494)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Dimt1-KO
系統ID
KOCMP-66254-Dimt1-B6J-VB
遺伝子名
製品ID
S-KO-18494
遺伝子別名
Dimt1l, 1500031M22Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 13
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000022203
NCBIトランスクリプトID
NM_025447
ターゲット領域
Exon 3~6
有効領域の大きさ
~2.5 kb
遺伝子研究の概要
Dimt1, short for dimethyladenosine transferase 1, is an evolutionarily conserved RNA N6,6-dimethyladenosine (m26,6A) methyltransferase. It plays a crucial role in ribosome biogenesis, and its catalytic activity is indispensable for cell viability and protein synthesis. Dimt1 is involved in pathways related to inter-generational hormesis, ribosomal processing, and may impact mitochondrial function. Genetic models such as Caenorhabditis elegans are valuable for studying its functions [1,2].
In C. elegans, parental starvation leads to inter-generational hormesis in progeny, which is accompanied by an increase in N6'-dimethyl adenosine (m6,2A) on 18S ribosomal RNA. DIMT-1/DIMT1 was identified as the m6,2A methyltransferase required for this inter-generational hormesis [1]. In human cells, DIMT1 generates m26,6A not only in 18S rRNA but also in small RNAs, and cells expressing catalytically inactive DIMT1 variants show decreased protein synthesis and cell viability [2]. In acute myeloid leukemia (AML), DIMT1 is essential for proliferation through a non-catalytic function. Targeting a positively charged cleft of DIMT1, remote from the catalytic site, weakens its binding to rRNA and mislocalizes it, affecting AML cell proliferation [3]. In gastric carcinoma, high DIMT1 expression correlates with tumor progression and poor prognosis [4]. In insects and C. elegans, the putative ortholog of human DIMT1 regulates lifespan [5]. In β-cells, DIMT1 controls protein synthesis, mitochondrial function, and insulin secretion, and its deficiency leads to perturbed insulin secretion, a potential pathogenic process in type 2 diabetes (T2D) [6]. In thyroid cancer, a PARP inhibitor inhibits DIMT1 transcription, leading to global translation inhibition [7]. Structural studies in human cells show that the catalytic activity of DIMT1 is involved in protein translation, and its overall protein scaffold is essential for 40S assembly [8]. Structural and functional characterization of archaeal DIMT1 reveals unique protein dynamics for efficient catalysis [9]. A study on the positively charged cleft of DIMT1 identified the minimum region to target for cell proliferation regulation [10].
In conclusion, Dimt1 is essential for ribosome biogenesis, cell viability, and protein synthesis. Model-based research, including studies in C. elegans, insects, and human cell lines, has revealed its roles in various biological processes and diseases such as inter-generational hormesis, cancer (AML, gastric carcinoma, thyroid cancer), lifespan regulation, and T2D. These findings contribute to understanding the molecular mechanisms underlying these biological phenomena and diseases, potentially guiding the development of new therapeutic strategies.
References:
1. Liberman, Noa, Rothi, M Hafiz, Gerashchenko, Maxim V, Gladyshev, Vadim N, Greer, Eric Lieberman. 2023. 18S rRNA methyltransferases DIMT1 and BUD23 drive intergenerational hormesis. In Molecular cell, 83, 3268-3282.e7. doi:10.1016/j.molcel.2023.08.014. https://pubmed.ncbi.nlm.nih.gov/37689068/
2. Shen, Hui, Gonskikh, Yulia, Stoute, Julian, Liu, Kathy Fange. 2021. Human DIMT1 generates N26,6A-dimethylation-containing small RNAs. In The Journal of biological chemistry, 297, 101146. doi:10.1016/j.jbc.2021.101146. https://pubmed.ncbi.nlm.nih.gov/34473991/
3. Gonskikh, Yulia, Stoute, Julian, Shen, Hui, Shi, Junwei, Liu, Kathy Fange. 2023. Noncatalytic regulation of 18S rRNA methyltransferase DIMT1 in acute myeloid leukemia. In Genes & development, 37, 321-335. doi:10.1101/gad.350298.122. https://pubmed.ncbi.nlm.nih.gov/37024283/
4. Liu, Guangyi, Peng, Xudong, Cai, Yongqian, Zha, Lang, Wang, Ziwei. 2017. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma. In Human pathology, 70, 35-42. doi:10.1016/j.humpath.2017.02.034. https://pubmed.ncbi.nlm.nih.gov/28601661/
5. Tao, Mei, Chen, Jiani, Cui, Chunlai, Huang, Jianhua, Shen, Xing-Xing. 2024. Identification of a longevity gene through evolutionary rate covariation of insect mito-nuclear genomes. In Nature aging, 4, 1076-1088. doi:10.1038/s43587-024-00641-z. https://pubmed.ncbi.nlm.nih.gov/38834883/
6. Verma, Gaurav, Bowen, Alexander, Gheibi, Sevda, Fex, Malin, Mulder, Hindrik. 2022. Ribosomal biogenesis regulator DIMT1 controls β-cell protein synthesis, mitochondrial function, and insulin secretion. In The Journal of biological chemistry, 298, 101692. doi:10.1016/j.jbc.2022.101692. https://pubmed.ncbi.nlm.nih.gov/35148993/
7. Hou, Xiukun, Tian, Mengran, Ning, Junya, Gao, Ming, Zheng, Xiangqian. 2023. PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause. In International journal of biological sciences, 19, 3970-3986. doi:10.7150/ijbs.81895. https://pubmed.ncbi.nlm.nih.gov/37564214/
8. Shen, Hui, Stoute, Julian, Liu, Kathy Fange. 2020. Structural and catalytic roles of the human 18S rRNA methyltransferases DIMT1 in ribosome assembly and translation. In The Journal of biological chemistry, 295, 12058-12070. doi:10.1074/jbc.RA120.014236. https://pubmed.ncbi.nlm.nih.gov/32616653/
9. Saha, Sayan, Kanaujia, Shankar Prasad. 2024. Structural and functional characterization of archaeal DIMT1 unveils distinct protein dynamics essential for efficient catalysis. In Structure (London, England : 1993), 32, 1760-1775.e7. doi:10.1016/j.str.2024.07.013. https://pubmed.ncbi.nlm.nih.gov/39146930/
10. Wei, Xiaoyu, Sampson, Nora, Figueroa Mendoza, Sarai Maria, Gonskikh, Yulia, Liu, Kathy Fange. 2025. Fault-Tolerance Study on a Positive-Charged Cleft in 18S rRNA Methyltransferase DIMT1. In Biochemistry, 64, 525-532. doi:10.1021/acs.biochem.4c00319. https://pubmed.ncbi.nlm.nih.gov/39762086/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
